Загрузка...
779. Impact of updated IDSA practice guidelines on the treatment of Clostridium difficile infections in the United States
BACKGROUND: IDSA published updated practice guidelines for C. difficile infections (CDI) in February 2018. Since publication of previous CDI guidelines in2010, randomized clinical trials (RCTs) have demonstrated benefit of oral (po) vancomycin or fidaxomicin over metronidazole in at least some types...
Сохранить в:
| Опубликовано в: : | Open Forum Infect Dis |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811244/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.847 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|